Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting

about

Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting

Item

http://www.wikidata.org/entity/Q58788707

description

scientific article published on 10 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@en

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@nl

type

Item

label

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@en

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@nl

prefLabel

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@en

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@nl

P1476

Cost-Effectiveness of Insulin ...... betes Mellitus in a UK Setting

@en

P2093

Barrie Chubb

http://www.w3.org/2001/XMLSchema#string

Jens Gundgaard

http://www.w3.org/2001/XMLSchema#string

Roopa Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoglycemia Event Rates: A Comparison Between Real-World Data and Randomized Controlled Trial Populations in Insulin-Treated Diabetes.

Cost-effectiveness of switching to insulin degludec from other basal insulins: evidence from Swedish real-world data.

Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.

Hypoglycemia, diabetes, and cardiovascular disease.

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

Benefits of probabilistic sensitivity analysis - a review of NICE decisions.

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.

The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics.

Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources

P2888

s13300-018-0478-1

P304

1919-1930

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-018-0478-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Evans

P577

2018-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30097995

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

Insulin

P932

6167291

http://www.w3.org/2001/XMLSchema#string